Healthcare share price target and research reports

Latest analyst research reports with target prices and PDF download for SECHEALTH, Healthcare

SECTOR | 24 Aug 2023

Q1FY24 result review : Seasonality restrains momentum

buy

ICICI Securities Limited

Seasonality on account of extended summers and holiday season impacted the operating matrix of hospitals under our coverage in Q1FY24. While their business model is prone to such cyclicality, companies were able to safeguard their ARPOB while occupancy took a slight hit.

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 05 Jul 2023

Q1FY24 preview: Hospital business steady; non-covid diagnostic ops surging

buy

ICICI Securities Limited

Surge in occupancy and ARPOB is likely to help hospitals under our coverage to report a revenue/EBITDA/PAT growth of 3%/7%/19% QoQ in Q1FY24E, respectively. The outlook remains steady for hospital chains as higher in-patient and surgery count is generating cashflow and the companies are diligently investing in expanding their network through M&A; or brownfield capex.

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 12 Jun 2023, 12:00AM

India’s healthcare players gear up for a once-in-a-decade opportunity

buy

Trendlyne Analysis

India’s healthcare industry has yielded impressive returns of over 12% in the past month. What is fueling this optimism among investors?

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 08 Jun 2023

Q4FY23 review: Operating matrix improving

buy

ICICI Securities Limited

Hospitals continue to maintain overall improvement in ARPOB and occupancy which had seen a surge post the outbreak of Covid-19. Most hospital chains are diligent in adding further beds to the network through M&A or brownfield capex. Non-covid revenues continue to witness steady 11-22% growth despite steep competitive pressure.

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 15 May 2023

Weathered storms to emerge stronger

buy

ICICI Securities Limited

The generic pharma business model in the US is undergoing a gradual shift and companies with specialised R&D skillsets will likely be able to tide over the transformation better. Windfall from gRevlimid and slowdown in intensity of pricing pressures have helped US sales of India companies to grow 6% in 9MFY23, while rationalisation of R&D spend (savings of 100bps in past 3 years) has aided margins.

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 10 Apr 2023

Result Preview: Hospitals

buy

ICICI Direct

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 06 Jan 2023

Healthcare

buy

Prabhudas Lilladhar

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 07 Oct 2022

Result Preview: Hospitals

buy

ICICI Direct

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 06 Oct 2022

Healthcare

buy

Prabhudas Lilladhar

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

SECTOR | 07 Jul 2022

Healthcare

buy

Prabhudas Lilladhar

Prabhudas Lilladhar released a Sector Update report for Healthcare on 08 Jul, 2025.

VOTE: What's your call on Healthcare?

2 Votes:

Buy 100.0%

RESEARCH REPORTS

Sector Update SEE REPORTS >

Sector Update SEE REPORTS >